HeartSciences (HSCS) Gross Profit (2021 - 2025)
HeartSciences filings provide 5 years of Gross Profit readings, the most recent being $1411.0 for Q4 2025.
- On a quarterly basis, Gross Profit changed N/A to $1411.0 in Q4 2025 year-over-year; TTM through Jan 2026 was $5021.0, a 59.89% decrease, with the full-year FY2025 number at $2470.0, down 80.27% from a year prior.
- Gross Profit hit $1411.0 in Q4 2025 for HeartSciences, up from $1140.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $10139.0 in Q1 2024 to a low of $1140.0 in Q3 2025.
- Median Gross Profit over the past 5 years was $1807.0 (2021), compared with a mean of $2637.7.
- Biggest five-year swings in Gross Profit: crashed 36.9% in 2023 and later surged 752.02% in 2024.
- HeartSciences' Gross Profit stood at $1728.0 in 2021, then tumbled by 32.64% to $1164.0 in 2022, then soared by 104.47% to $2380.0 in 2023, then soared by 326.01% to $10139.0 in 2024, then crashed by 86.08% to $1411.0 in 2025.
- The last three reported values for Gross Profit were $1411.0 (Q4 2025), $1140.0 (Q3 2025), and $2470.0 (Q2 2025) per Business Quant data.